Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as a chemotherapeutic agent in endometrial carcinoma
IRCT20220409054463N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of metformin in endometrial cancer (EC), sponsored by Shahid Beheshti University of Medical Sciences. Started Jun 2022; status: completed.
02
Drugs
metformin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on IRCT20220409054463N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220409054463N1.